Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor in Patients With Newly Diagnosed or Recurrent Malignant Gliomas: A Safety, Histopathology, and Correlative Biomarker Study

NCT02632370 is registered in ClinicalTrials.gov with Constantinos Hadjipanayis as lead sponsor.

NCT NCT02632370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02632370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor in Patients With Newly Diagnosed or Recurrent Malignant Gliomas: A Safety, Histopathology, and Correlative Biomarker Study
Lead sponsor
Constantinos Hadjipanayis
Phase
Observational
Overall status
Completed
Start date
May 31, 2016
Completion date
December 31, 2018
Enrollment
69 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

malignant gliomas